x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

On the Frontlines of Psoriasis

Stay up to date on the latest advancements in the management of one of the most common types of skin diseases with our exclusive podcast series, On the Frontlines of Psoriasis. Tune in to hear from leading dermatology experts as they explore key diagnosis and treatment strategies in addition to the ongoing research that’s reshaping our understanding of this common and chronic disease.

science & medicine medicine

All Episodes

00:00:00

Genetics in Psoriasis: Impacts on Risk,...

On the Frontlines of Psoriasis ·

2025/07/23

Guest: Audrey Bui, DO Genetic insights are reshaping how we understand the development and comorbidities of psoriasis, as well as treatment response in patients. Hear Dr. Audrey Bui discuss how genetic variants influence risks for certain conditions, how they may predict response to therapies like methotrexate, ustekinumab, and IL-17 inhibitors, and how integrating genetic markers into clinical care can enable more targeted, effective psoriasis management. Dr. Bui is a recent graduate

en

00:00:00

Skin Disease and Cardiovascular Risk: Uncovering a...

On the Frontlines of Psoriasis ·

2025/06/10

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Joel M. Gelfand, MD, MSCE, FAAD Guest: Michael S. Garshick, MD Inflammatory skin diseases like psoriasis don’t just affect the skin—they can often reflect broader cardiovascular risks. Given the overlap between dermatology and cardiology, knowing how to spot warning signs early and what steps to take during routine visits is key to comprehensive care. Joining Dr. Mary Cheeley to discuss the connection between the skin

en

00:00:00

Comparing Home and Office-Based UVB Phototherapy:...

On the Frontlines of Psoriasis ·

2025/06/03

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joel M. Gelfand, MD, MSCE, FAAD Guest: Valerie Harrison, PhD Home-based narrowband UVB phototherapy may offer a more accessible and effective option for managing psoriasis, as shown by the results of a recent study. With benefits like improved adherence, lower costs, and greater accessibility, this approach offers a compelling alternative for patients managing chronic disease. Explore the implications of this research and how it

en

00:00:00

Examining Psoriasis Prevalence: Diagnostic...

On the Frontlines of Psoriasis ·

2025/05/14

Guest: Joe K. Tung, MD, MBA Psoriasis affects nearly eight million adults in the US, but its impact isn’t felt equally; significant disparities in diagnosis exist across race, ethnicity, and socioeconomic status. Join Dr. Joe Tung as he discusses his recent analysis of data from the National Health Interview Survey, in which he explored the most affected patient populations, the potential for underdiagnosis, and the broader ties between psoriasis, metabolic health, and life

en

00:00:00

Future Directions in Psoriasis Treatment: Innovations...

On the Frontlines of Psoriasis ·

2025/04/21

Guest: Andrew Blauvelt, MD, MBA From novel oral therapies to advancements in biologic injections, the treatment landscape for psoriasis is rapidly evolving. Here to share his insights on how these new treatment strategies could improve efficacy, reduce safety concerns, and even make once-yearly biologic dosing a reality is Dr. Andrew Blauvelt. Dr. Blauvelt is a dermatologist and clinical researcher with a focus on innovative treatments for psoriasis.

en

00:00:00

Scalp Psoriasis Care: When Should Systemic Therapy Be...

On the Frontlines of Psoriasis ·

2025/04/21

Guest: Andrew Blauvelt, MD, MBA While systemic therapies like deucravacitinib have previously only been recommended for patients with moderate-to-severe plague psoriasis, it may be worth questioning whether body surface area alone is enough to dictate its use. Learn when scalp psoriasis may call for systemic therapies with Dr. Andrew Blauvelt, a dermatologist and clinical researcher with a focus on innovative treatments for psoriasis.

en

00:00:00

Looking Beyond the Skin: The Far-Reaching Impacts of...

On the Frontlines of Psoriasis ·

2025/04/21

Guest: Philip J. Mease, MD Psoriasis is more than just a skin condition—it can significantly impact a patient’s relationships, daily functioning, and overall quality of life. Tune in to hear Dr. Philip J. Mease discuss the multidimensional nature of psoriasis and the importance of a holistic approach to care. Dr. Mease is the Director of Rheumatology Research at Providence Swedish Medical Center and Clinical Professor at the University of Washington.

en

00:00:00

Examining the Mediterranean Diet’s Potential in...

On the Frontlines of Psoriasis ·

2025/04/01

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joel M. Gelfand, MD, MSCE Researchers speculate that the Mediterranean Diet may have benefits for psoriasis patients because of its anti-inflammatory effects. In fact, a recent study has been examining the relationship between the Mediterranean Diet and factors like skin health, quality of life, and markers of inflammation in the blood. Join Dr. Joel M. Gelfand, Director of the Psoriasis and Phototherapy Treatment Center and Director

en

00:00:00

Psoriasis and Mortality: New Data on Life Expectancy

On the Frontlines of Psoriasis ·

2025/02/20

Guest: Robert Gniadecki, MD A recent retrospective study using the Alberta Health Services Data Repository of Reporting found that patients with psoriasis had a significantly lower lifespan than a control group of patients with a comparable health profile. Join Dr. Robert Gniadecki, Professor and Director of the Division of Dermatology at the University of Alberta, as he dives into this data and explains implications for clinical practice.

en

00:00:00

Scalp Psoriasis Treatment: Examining...

On the Frontlines of Psoriasis ·

2025/02/19

Guest: Andrew Blauvelt, MD, MBA As the only FDA-designated selective TYK2 inhibitor, deucravacitinib has emerged as a potential therapeutic option for scalp psoriasis. And after analyzing its impacts in a phase III clinical trial, it has continued to show promise in terms of both efficacy and safety. Hear more about deucravacitinib and how it compares to alternate options like JAK inhibitors from Dr. Andrew Blauvelt, a dermatologist and clinical researcher with a focus on innovative

en

00:00:00

Long-Term Safety of Ixekizumab for Psoriasis: A...

On the Frontlines of Psoriasis ·

2025/02/18

Guest: Atul A. Deodhar, MD, MRCP Managing psoriasis, psoriatic arthritis, and axial spondyloarthritis with ixekizumab may cause adverse effects in patients. That’s why a recent research review further investigated the safety of this treatment over time, analyzing data from 25 clinical trials and noting common side effects. Learn more about ixekizumab’s long-term use with Dr. Atul Deodhar, the lead author of this study. He’s also a Professor of Medicine and the Medical Director of

en

00:00:00

Factors Influencing Biologic Therapy Switching in...

On the Frontlines of Psoriasis ·

2025/02/11

Guest: Philip J. Mease, MD A recent study led by Dr. Philip J. Mease examined the factors contributing to biologic therapy switching among patients with psoriasis and psoriatic arthritis. Using data from the CorEvitas Psoriasis Registry, the study identified key drivers, including high Psoriasis Area and Severity Index (PASI) scores, poor quality of life, and significant joint pain. Tune in to learn more about these findings and their implications for patient care with Dr. Mease,

en

00:00:00

Study: Psoriasis Patients with Skin of Color Wait 3x...

On the Frontlines of Psoriasis ·

2024/07/05

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Taylor Dickerson, MD According to a recent study, patients with skin of color waited three times longer to be formally diagnosed with psoriasis and were almost four times more likely to be biopsied compared to non-Hispanic patients. And as a result, these patients were more likely to present with severe disease, greatly impacting their overall quality of life. To learn more about this study’s findings and how we can address racial

en

00:00:00

Adherence Amplified: Optimizing Topical Therapy for...

On the Frontlines of Psoriasis ·

2024/06/18

Host: Raj Chovatiya, MD, PhD Guest: Steven R. Feldman, MD, PhD According to recent studies, only about 50 percent of psoriasis patients are adherent to topical medications by the end of an eight-week treatment period. This can have a significant impact on a patient’s overall quality of life and outcomes, which is why Dr. Raj Chovatiya speaks with Dr. Steven Feldman about strategies to improve psoriasis patients’ adherence to topical agents. Dr. Feldman is a Professor of

en

00:00:00

Dermatological Strategies for Challenging Cases of...

On the Frontlines of Psoriasis ·

2018/12/10

Host: Matt Birnholz, MD Guest: Mark G. Lebwohl, MD Here to give us insight into the strategies he uses to personalize therapeutic approaches for his patients with severe psoriasis is Dr. Mark Lebwohl, professor and chairman of the Department of Dermatology at The Mount Sinai School of Medicine.

en

00:00:00

A Memorable Patient Case: Psoriasis & IBD

On the Frontlines of Psoriasis ·

2018/12/10

Host: Matt Birnholz, MD Guest: Mark G. Lebwohl, MD Tune in as Dr. Mark Lebwohl, professor and chairman of the Department of Dermatology at The Mount Sinai School of Medicine, shares a challenging case of a patient with both psoriasis and Crohn's disease.

en

16 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事